New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia

被引：18

作者：

Adhyaru, Bhavin B. ^{[1
]}

Jacobson, Terry A. ^{[2
]}

机构：

[1] Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA

[2] Emory Univ, Sch Med, Dept Med, Lipid Clin & Cardiovasc Risk Reduct Program, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2016年 / 45卷 / 01期

关键词：

Clinical recommendations; Guidelines; Low-density lipoprotein cholesterol (LDL-C); Atherosclerotic cardiovascular disease (ASCVD); Dyslipidemia; Atherogenic cholesterol; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; PRIMARY PREVENTION; LDL CHOLESTEROL; HDL CHOLESTEROL; STATIN THERAPY; EVENTS; ROSUVASTATIN; METAANALYSIS; REDUCTION;

D O I：

10.1016/j.ecl.2015.09.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review discusses the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and compares it with the 2014 National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia. The review discusses some of the distinctions between the guidelines, including how to determine a patient's atherosclerotic cardiovascular disease risk, the role of lipoprotein treatment targets, the importance of moderate- and high intensity statin therapy, and the use of nonstatin therapy in light of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) trial.

引用

页码：17 / +

页数：22

共 52 条

[1] Statin-induced myopathy: a review and update [J].

Abd, Thura T. ;

Jacobson, Terry A. .

EXPERT OPINION ON DRUG SAFETY, 2011, 10 (03) :373-387

[2]

Association AH, 2013, 2013 PREV GUID TOOLS

[3] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].

Baigent, C. ;

Blackwell, L. ;

Emberson, J. ;

Holland, L. E. ;

Reith, C. ;

Bhala, N. ;

Peto, R. ;

Barnes, E. H. ;

Keech, A. ;

Simes, J. ;

Collins, R. .

LANCET, 2010, 376 (9753) :1670-1681

[4] Multi-ethnic study of atherosclerosis: Objectives and design [J].

Bild, DE ;

Bluemke, DA ;

Burke, GL ;

Detrano, R ;

Roux, AVD ;

Folsom, AR ;

Greenland, P ;

Jacobs, DR ;

Kronmal, R ;

Liu, K ;

Nelson, JC ;

O'Leary, D ;

Saad, MF ;

Shea, S ;

Szklo, M ;

Tracy, RP .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881

[5] Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].

Boden, William E. ;

Probstfield, Jeffrey L. ;

Anderson, Todd ;

Chaitman, Bernard R. ;

Desvignes-Nickens, Patrice ;

Koprowicz, Kent ;

McBride, Ruth ;

Teo, Koon ;

Weintraub, William .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267

[6] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].

Boekholdt, S. Matthijs ;

Arsenault, Benoit J. ;

Mora, Samia ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Nestel, Paul J. ;

Simes, R. John ;

Durrington, Paul ;

Hitman, Graham A. ;

Welch, K. M. A. ;

DeMicco, David A. ;

Zwinderman, Aeilko H. ;

Clearfield, Michael B. ;

Downs, John R. ;

Tonkin, Andrew M. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Kastelein, John J. P. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309

[7] Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study [J].

Bruckert, E ;

Hayem, G ;

Dejager, S ;

Yau, C ;

Bégaud, B .

CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) :403-414

[8]

Buchwald H, 2001, CIRCULATION, V104, pE47

[9] Is diabetes a coronary risk equivalent? Systematic review and meta-analysis [J].

Bulugahapitiya, U. ;

Siyambalapitiya, S. ;

Sithole, J. ;

Idris, I. .

DIABETIC MEDICINE, 2009, 26 (02) :142-148

[10] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].

CANNER, PL ;

BERGE, KG ;

WENGER, NK ;

STAMLER, J ;

FRIEDMAN, L ;

PRINEAS, RJ ;

FRIEDEWALD, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255

← 1 2 3 4 5 6 →